InvestorsHub Logo
Followers 17
Posts 752
Boards Moderated 0
Alias Born 10/20/2013

Re: USS Vengeance post# 345

Wednesday, 08/17/2016 9:43:44 AM

Wednesday, August 17, 2016 9:43:44 AM

Post# of 733
I believe Switzerland is paying app. $20k per implant and that several insurance companies have agreed to reimburse at this level for the next 6 months. I think Switzerland will come around and eventually pay up on a permanent basis. It is tricky, though, because Clinuvel hasn't yet applied for formal approval in Switzerland and it seems it's not a high priority issue for them right now, which is understandable from a fiscal point of view.

Italy: I don't know what happened but but it sure seems that the compassionate use scheme is boomeranging on Clinuvel today going into the commercial phase. I wouldn't worry, though. Germany is prepared to pay a rather high price and after negotiations with the statutory health insurance (SHI) I think we will end up at app. $20-22k excluding VAT per implant. At some point Italy will have to come around too.

Once NICE HST has negotiated a price with Clinuvel in (hopefully) 4-6 months I think the German and British price level will become a benchmark price for many of those counties who usually look to the bigger counties when agreeing to reimburse.
The Scandinavian countries (excluding Norway who has a NICE-like institute) usually pay full price without asking many questions. It puzzles me why Sweden and Denmark aren't online yet. Usually, these are first mover markets with very little red tape. Perhaps Clinuvel hasn't had time to submit the need documentation yet as is seems is also the case in Norway. Here, Helse Bergen has unilaterally initiated the reimbursement process but it seems that the process is stalled because Clinuvel hasn't yet submitted the data package. They must be very busy and prioritizing the bigger markets.